| Authors: |
Mitra S; Centre on Drug Policy Evaluation, MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada., Scheim AI; Centre on Drug Policy Evaluation, MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada; The Williams Institute, UCLA School of Law, University of California, Los Angeles, CA, United States., Owusu-Bempah A; Department of Sociology, University of Toronto, Toronto, ON, Canada., Eeuwes J; Centre on Drug Policy Evaluation, MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada., Olson-Pitawanakwat B; Toronto Indigenous Harm Reduction, Toronto, ON, Canada., Smoke A, Bayoumi A; MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada., Werb D; Centre on Drug Policy Evaluation, MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada; Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, United States. Electronic address: dwerb@health.ucsd.edu. |
